First Horizon Corporation’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23M Sell
63,631
-1,044
-2% -$357K 0.89% 32
2026
Q1
$22.8M Buy
64,675
+13,857
+27% +$4.94M 0.95% 28
2025
Q4
$16.6M Sell
50,818
-589
-1% -$187K 0.74% 40
2025
Q3
$14.5M Buy
+51,407
New +$14.9M 0.68% 44
2021
Q2
$3.67M Sell
15,070
-429
-3% -$106K 0.33% 91
2021
Q1
$3.86M Buy
15,499
+242
+2% +$57.7K 0.37% 83
2020
Q4
$3.51M Buy
15,257
+314
+2% +$72.4K 0.35% 84
2020
Q3
$3.8M Buy
+14,943
New +$3.7M 0.4% 81
2013
Q2
$273K Buy
+2,776
New +$288K 0.07% 200

Other funds holding AMGN

First Horizon Corporation's AMGN Position: Q2 2026 in Review

First Horizon Corporation reduced its Amgen (AMGN) stake by 1.6% in Q2 2026, selling an estimated $357K and leaving 63,631 shares worth $23M. The position accounts for 0.89% of the portfolio, ranked #32.

First Horizon Corporation first reported a position in AMGN in Q2 2013 and has held it in 9 quarters since. 1,171 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • First Horizon Corporation held 63,631 shares of Amgen worth $23M as of Q2 2026.
  • First Horizon Corporation sold 1,044 Amgen shares in Q2 2026, an estimated $357K.
  • Amgen made up 0.89% of First Horizon Corporation's portfolio in Q2 2026, its #32 holding.
  • First Horizon Corporation first reported a position in Amgen in Q2 2013 and has held it in 9 quarters since.
  • 1,171 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.